-
A test that detects antibodies to the novel coronavirus in 10 minutes and costs only a fifth of the market average has been developed by researchers at the University of São Paulo's São Carlos Chemistry Institute (IQSC-USP) and Brazilian startup Biolinker, with São Paulo Research Foundation - FAPESP's support.
The device works similarly to the rapid tests available now in pharmacies. It analyzes a drop of blood, and two red LEDs light up if it detects the presence [...]
-
Technology based on nanoparticles identifies IgG antibodies and costs only about a fifth of similar devices now on the market. It was developed by scientists at the University of São Paulo and Brazilian startup Biolinker.
A test that detects antibodies to the novel coronavirus in 10 minutes and costs only a fifth of the market average has been developed by researchers at the University of São Paulo’s São Carlos Chemistry Institute (IQSC-USP) and Brazilian startup [...]
-
A test that detects antibodies to the novel coronavirus in 10 minutes and costs only a fifth of the market average has been developed by researchers at the University of São Paulo's São Carlos Chemistry Institute (IQSC-USP) and Brazilian startup Biolinker, with São Paulo Research Foundation—FAPESP's support.
The device works similarly to the rapid tests available now in pharmacies. It analyzes a drop of blood, and two red LEDs light up if it detects [...]
-
A test that detects antibodies to the novel coronavirus in 10 minutes and costs only a fifth of the market average has been developed by researchers at the University of São Paulo’s São Carlos Chemistry Institute (IQSC-USP) and Brazilian startup Biolinker, with São Paulo Research Foundation – FAPESP’s support.
The device works similarly to the rapid tests available now in pharmacies. It analyzes a drop of blood, and two red LEDs light up if it detects the [...]
-
A test that detects antibodies to the novel coronavirus in 10 minutes and costs only a fifth of the market average has been developed by researchers at the University of São Paulo’s São Carlos Chemistry Institute (IQSC-USP) and Brazilian startup Biolinker, with São Paulo Research Foundation—FAPESP’s support.
The device works similarly to the rapid tests available now in pharmacies. It analyzes a drop of blood, and two red LEDs light up if it detects the [...]
-
A test that detects antibodies to the novel coronavirus in 10 minutes and costs only a fifth of the market average has been developed by researchers at the University of São Paulo’s São Carlos Chemistry Institute (IQSC-USP) and Brazilian startup Biolinker, with São Paulo Research Foundation—FAPESP’s support.
The device works similarly to the rapid tests available now in pharmacies. It analyzes a drop of blood, and two red LEDs light up if it detects the [...]
-
Um teste capaz de detectar anticorpos contra o novo coronavírus em apenas 10 minutos – a um custo até cinco vezes menor que a média de mercado – foi desenvolvido por pesquisadores do IQSC (Instituto de Química de São Carlos da Universidade de São Paulo) e da startup paulistana Biolinker, com apoio da FAPESP.
O dispositivo funciona de forma semelhante à dos testes rápidos já disponíveis nas [...]
-
Pesquisadores da USP criaram novo teste para detectar o vírus e pode custar até cinco vezes mais baratos que a média de mercado
Pesquisadores da Universidade de São Paulo (USP) desenvolveram um novo teste para a Covid-19, capaz de detectar a doença em 10 minutos. Ele é mais popular e custa até cinco vezes menos que a média de mercado, ou seja, ele é mais barato que os outros testes disponíveis. Conhecido como [...]
-
Pesquisadores da Universidade de São Paulo (USP) desenvolveram um novo teste para a Covid-19 , capaz de detectar a doença em 10 minutos. Ele é mais popular e custa até cinco vezes menos que a média de mercado, ou seja, ele é mais barato que os outros testes disponíveis. Conhecido como “Teste Popular de COVID-19”, ele poderá ser vendido por 30 reais, assim que obtiver o registro na Anvisa (Agência Nacional de [...]
-
Um teste capaz de detectar anticorpos contra o novo coronavírus em apenas 10 minutos – a um custo até cinco vezes menor que a média de mercado – foi desenvolvido por pesquisadores do Instituto de Química de São Carlos da Universidade de São Paulo (IQSC) e da startup paulistana Biolinker, com apoio da FAPESP. » Veja mais...
